Events, news, information and findings.

We are committed to providing a transparent view of our business. In light of this commitment, our Press Room offers media professionals with frequently requested materials to expedite inquiries into Vertex, our pipeline and our people.

You’ll find an archive of Vertex press releases, media contacts, management bios, related photographs and images, product background documents, corporate logos and other materials.

Latest Press Releases

Feb 2, 2012		Vertex Reports Fourth Quarter and Full-Year 2011 Financial Results
Jan 31, 2012		ADDING MULTIMEDIA FDA Approves KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Jan 31, 2012		FDA Approves KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Jan 17, 2012		Vertex Announces the Date of its Full Year 2011 Financial Results Conference Call and Webcast
Jan 8, 2012		Vertex Announces Key 2012 Business Objectives as Company Prepares for Planned Global Launch of KALYDECO in Cystic Fibrosis

See more Press Releases

Hepatitis C Resource Center

Hepatitis C Media Handbook
Hepatitis C Backgrounder
Treatment Response in Hepatitis C
Hepatitis C Glossary

Cystic Fibrosis Resource Center

Cystic Fibrosis Backgrounder
Symptoms of Cystic Fibrosis (CF)
Role of Cystic Fibrosis transmembrane conductance regulator (CFTR) in CF
Gene Mutations in CF
Cystic Fibrosis Glossary

Media Contacts

For Media Professionals Only
Vertex welcomes inquiries from members of the media and will respond to such inquiries as quickly as possible.

The contact information listed below is for use by media professionals only. If you are not a media professional (reporter, journalist, producer, freelance writer, etc.), please visit our Contact Page so that your inquiry can be directed to the appropriate department.

General Media Inquiries and Interview Requests for Vertex Spokespeople:

Media Hotline: 617-444-6992
Media Email: mediainfo@vrtx.com

To receive Vertex's press releases by email, please sign up for Email & News Alerts.